03 Mar 2017
ReproCELL Europe's CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research
ReproCELL Europe's CEO, Dr David Bunton presented at the recent NC3Rs meeting on the use of human tissues in cancer research. The conference considered the potential for human tissue models to help reduce clinical drug attrition and provide more relevant models of cancer using techniques such as 3D models, PDX systems and precision-cut tumour slices.
Read more

14 Feb 2017
ReproCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan
ReproCELL Inc. (Japan)s CEO Dr Chikafumi Yokoyama had the honour of meeting with Fiona Hyslop, Cabinet Secretary for Culture, Tourism and External Affairs for the Scottish Government, during her visit to the Scottish Enterprise Tokyo office, today (14 February 2017).
Read more

07 Feb 2017
Scottish Enterprise Association Honours ReproCELL with Annual Awards Nomination
Scottish Enterprise Association Honours ReproCELL with Annual Awards Nomination
Read more

More >


I am very pleased with our cooperation so far; nice data and very good fit to our internal knowledge of the compounds

Senior Scientist, Top 20 European Pharma

We used Biopta because they are able to provide sensitive and accurate information from a wide range of different types of tissue

CEO, UK Biotech

Biopta's human tissue services have played a critical part in our compound selection and have added considerable value to our lead compound

President & Head of R&D, Canadian Biotech
Live chat by BoldChat